OPIMEND

Opimend Ltd, based in the Weizmann Science Park, Israel, is a fully owned subsidiary of Drug Rediscovery Group Ltd (DRG). DRG redefines drug repurposing by focusing on established drugs that have established clinical proof of efficacy... Opimend's sole focus is to develop repurposed drugs that are able to play critical roles in solving the opioid crisis. Through Opimend's consolidated pipeline for safe and established drugs, we are poised to have ready-to-market drugs starting from Q4 of 2020.

Also known as: Opimend Ltd.

Primary location: Rehovot Israel